Join
Live feed
·
PRReleasevia Quantisnow
InspireMD Inc. logo

InspireMD Supports CMS' Final National Coverage Determination (NCD) Expanding Coverage of Carotid Stenting (CAS) to Include Both Asymptomatic and Standard Risk Patients

ByQuantisnow·Wall Street's wire, on your screen.
NSPR· InspireMD Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NSPR (InspireMD Inc.) and more on Quantisnow.